These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 34231858)
1. [Clozapine treatment and COVID-19: continue despite leukocytopenia and increase of clozapine serum levels]. Smits F; Bogers JPAM; de Leeuw M Tijdschr Psychiatr; 2021; 63(6):406-411. PubMed ID: 34231858 [TBL] [Abstract][Full Text] [Related]
2. COVID-19 infection causes a reduction in neutrophil counts in patients taking clozapine. Gee S; Taylor D J Psychiatry Neurosci; 2021 Mar; 46(2):E232-E237. PubMed ID: 33703870 [TBL] [Abstract][Full Text] [Related]
3. Outcome of COVID-19 mRNA Vaccination in Patients Treated With Clozapine WHO Previously Went Through SARS-COV-2 Infection. Moga S; Petric PS; Miron AA; Ifteni P; Teodorescu A Am J Ther; 2023 May; 30(3):e186-e196. PubMed ID: 37097999 [TBL] [Abstract][Full Text] [Related]
4. Does switching to another antipsychotic in patients with clozapine-associated granulocytopenia solve the problem? Case series of 18 patients. Coşar B; Taner ME; Eser HY; Altınöz AE; Tarhan R J Clin Psychopharmacol; 2011 Apr; 31(2):169-73. PubMed ID: 21346615 [TBL] [Abstract][Full Text] [Related]
5. Clozapine-induced leukopenia successfully treated with lithium. Kutscher EC; Robbins GP; Kennedy WK; Zebb K; Stanley M; Carnahan RM Am J Health Syst Pharm; 2007 Oct; 64(19):2027-31. PubMed ID: 17893412 [TBL] [Abstract][Full Text] [Related]
6. Clozapine-induced bicytopenia: An unusual side effect. Faye AD; Kirpekar VC; Tadke R; Gawande S; Bhave SH Indian J Pharmacol; 2018; 50(2):88-90. PubMed ID: 30100657 [TBL] [Abstract][Full Text] [Related]
7. COVID-19: Risks, Complications, and Monitoring in Patients on Clozapine. Veerman SRT; Bogers JPAM; Cohen D; Schulte PFJ Pharmacopsychiatry; 2022 Jan; 55(1):48-56. PubMed ID: 34470068 [TBL] [Abstract][Full Text] [Related]
8. Prolongation of clozapine-induced leukopenia with olanzapine treatment. Sayin A; Cosar B Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):958-9. PubMed ID: 16631295 [TBL] [Abstract][Full Text] [Related]
9. Clozapine-induced agranulocytosis in Japan: Changes in leukocyte/neutrophil counts before and after discontinuation of clozapine. Matsui K; Ishibashi M; Kawano M; Oshibuchi H; Ishigooka J; Nishimura K; Inada K Hum Psychopharmacol; 2020 Jul; 35(4):e2739. PubMed ID: 32420645 [TBL] [Abstract][Full Text] [Related]
10. Clozapine: the commitment to patient safety. Alphs LD; Anand R J Clin Psychiatry; 1999; 60 Suppl 12():39-42. PubMed ID: 10372610 [TBL] [Abstract][Full Text] [Related]
11. The incidence of clozapine-induced leukopenia in patients with schizophrenia at Srinagarind Hospital. Maskasame S; Krisanaprakornkit T; Khiewyoo J J Med Assoc Thai; 2007 Oct; 90(10):2175-80. PubMed ID: 18041439 [TBL] [Abstract][Full Text] [Related]
12. Increase in white cell and neutrophil counts during the first eighteen weeks of treatment with clozapine in patients admitted to a long-term psychiatric care inpatient unit. Capllonch A; de Pablo S; de la Torre A; Morales I Rev Psiquiatr Salud Ment (Engl Ed); 2018; 11(2):94-100. PubMed ID: 27156787 [TBL] [Abstract][Full Text] [Related]
13. Clozapine treatment: Ensuring ongoing monitoring during the COVID-19 pandemic. Nystazaki M; Alevizopoulos G Psychiatriki; 2021 Jul; 32(2):165-166. PubMed ID: 33759812 [TBL] [Abstract][Full Text] [Related]
14. Reduction in Absolute Neutrophil Counts in Patient on Clozapine Infected with COVID-19. Ramli FF; Ali A; Syed Hashim SA; Kamisah Y; Ibrahim N Int J Environ Res Public Health; 2021 Oct; 18(21):. PubMed ID: 34769806 [TBL] [Abstract][Full Text] [Related]
15. Clozapine and COVID-19 Vaccination: Effects on blood levels and leukocytes. An observational cohort study. Veerman SRT; Moscou T; Bogers JPAM; Cohen D; Schulte PFJ Acta Psychiatr Scand; 2022 Aug; 146(2):168-178. PubMed ID: 35322409 [TBL] [Abstract][Full Text] [Related]
16. Clozapine-induced agranulocytosis and leukopenia: Incidence, associated factors, and rate of hematologic adverse-effects monitoring in psychiatric out-patient services in Thailand. Tunsirimas N; Pariwatcharakul P; Choovanichvong S; Ratta-Apha W Asian J Psychiatr; 2019 Mar; 41():13-16. PubMed ID: 30856469 [TBL] [Abstract][Full Text] [Related]
17. [COVID-19 and severe mental illness, especially in clozapine use]. Veerman SRT; Bogers JPAM; Cohen D; Schulte PFJ Tijdschr Psychiatr; 2021; 63(7):499-508. PubMed ID: 34523699 [TBL] [Abstract][Full Text] [Related]
18. Neutropenia in Patients With Clozapine-Treated Schizophrenia: An Effect of Clozapine or a Consequence of SARS-CoV-2 Infection? A Systematic Review. Moga S; Teodorescu A; Dragan A; Miron AA; Ifteni P Am J Ther; 2022 Sep-Oct 01; 29(5):e544-e552. PubMed ID: 35749754 [TBL] [Abstract][Full Text] [Related]
19. Safety of a Clozapine Trial Following Quetiapine-Induced Leukopenia: A Case Report. Almaghrebi AH Curr Drug Saf; 2019; 14(1):80-83. PubMed ID: 30084338 [TBL] [Abstract][Full Text] [Related]
20. Current practice for clozapine-induced leukopenia in Japanese psychiatric hospitals: A nationwide survey. Niitsu T; Yasui-Furukori N; Inada K; Kanazawa T; Iyo M; Ueno T; Hashimoto R Schizophr Res; 2024 Jun; 268():82-87. PubMed ID: 38038428 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]